These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 38953039)

  • 1. Baseline Lung Allograft Dysfunction After Bilateral Lung Transplantation Is Associated With an Increased Risk of Death: Results From a Multicenter Cohort Study.
    Keller MB; Sun J; Alnababteh M; Ponor L; D Shah P; Mathew J; Kong H; Charya A; Luikart H; Aryal S; Nathan SD; Orens JB; Khush KK; Kyoo Jang M; Agbor-Enoh S
    Transplant Direct; 2024 Jul; 10(7):e1669. PubMed ID: 38953039
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Baseline lung allograft dysfunction is associated with impaired survival after double-lung transplantation.
    Liu J; Jackson K; Weinkauf J; Kapasi A; Hirji A; Meyer S; Mullen J; Nagendran J; Lien D; Halloran K
    J Heart Lung Transplant; 2018 Jul; 37(7):895-902. PubMed ID: 29602706
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of Baseline Lung Allograft Dysfunction in Single Lung Transplant Recipients.
    Gerckens M; Mümmler C; Richard A; Strodel J; Mertsch P; Milger K; Veit T; Gade N; Yildirim AÖ; Schneider C; Kauke T; Michel S; Irlbeck M; Behr J; Kneidinger N
    Transplantation; 2024 Sep; ():. PubMed ID: 39250332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Baseline lung allograft dysfunction after bilateral deceased-donor lung transplantation: A single-center experience in Japan.
    Yamaguchi M; Kawashima M; Muraoka T; Yamaya T; Cong Y; Nakao K; Nagano M; Konoeda C; Kage H; Sato M
    Respir Investig; 2024 Sep; 62(5):838-843. PubMed ID: 39047315
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Airway oscillometry parameters in baseline lung allograft dysfunction: Associations from a multicenter study.
    Darley DR; Nilsen K; Vazirani J; Borg BM; Levvey B; Snell G; Plit ML; Tonga KO
    J Heart Lung Transplant; 2023 Jun; 42(6):767-777. PubMed ID: 36681528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Baseline lung allograft dysfunction in primary graft dysfunction survivors after lung transplantation.
    Li D; Weinkauf J; Kapasi A; Hirji A; Varughese R; Lien D; Nagendran J; Halloran K
    Respir Med; 2021 Nov; 188():106617. PubMed ID: 34571454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Azithromycin prophylaxis after lung transplantation is associated with improved overall survival.
    Li D; Duan Q; Weinkauf J; Kapasi A; Varughese R; Hirji A; Lien D; Meyer S; Laing B; Nagendran J; Halloran K
    J Heart Lung Transplant; 2020 Dec; 39(12):1426-1434. PubMed ID: 33041181
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal one-year post-lung transplant spirometry is a significant predictor of increased mortality and chronic lung allograft dysfunction.
    Paraskeva MA; Borg BM; Paul E; Fuller J; Westall GP; Snell GI
    J Heart Lung Transplant; 2021 Dec; 40(12):1649-1657. PubMed ID: 34548197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and Refinement of Chronic Lung Allograft Dysfunction Phenotypes in Bilateral and Single Lung Recipients.
    DerHovanessian A; Todd JL; Zhang A; Li N; Mayalall A; Finlen Copeland CA; Shino M; Pavlisko EN; Wallace WD; Gregson A; Ross DJ; Saggar R; Lynch JP; Belperio J; Snyder LD; Palmer SM; Weigt SS
    Ann Am Thorac Soc; 2016 May; 13(5):627-35. PubMed ID: 27144793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Three-year survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999.
    Smits JM; Vanhaecke J; Haverich A; de Vries E; Smith M; Rutgrink E; Ramsoebhag A; Hop A; Persijn G; Laufer G
    Clin Transpl; 2003; ():89-100. PubMed ID: 15387100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Atelectasis in primary graft dysfunction survivors after lung transplantation.
    Li D; Abele J; Weinkauf J; Kapasi A; Hirji A; Varughese R; Nagendran J; Lien D; Doucette K; Halloran K
    Clin Transplant; 2021 Jul; 35(7):e14315. PubMed ID: 33848359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of donor-derived-cell-free DNA as a marker of early allograft injury in primary graft dysfunction (PGD) to predict the risk of chronic lung allograft dysfunction (CLAD).
    Keller M; Bush E; Diamond JM; Shah P; Matthew J; Brown AW; Sun J; Timofte I; Kong H; Tunc I; Luikart H; Iacono A; Nathan SD; Khush KK; Orens J; Jang M; Agbor-Enoh S
    J Heart Lung Transplant; 2021 Jun; 40(6):488-493. PubMed ID: 33814284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell-Free DNA Maps Tissue Injury and Correlates with Disease Severity in Lung Transplant Candidates.
    Balasubramanian S; Richert ME; Kong H; Fu S; Jang MK; Andargie TE; Keller MB; Alnababteh M; Park W; Apalara Z; Sun J; Redekar N; Orens J; Aryal S; Bush EL; Cantu E; Diamond J; Shah P; Yu K; Nathan SD; Agbor-Enoh S
    Am J Respir Crit Care Med; 2024 Mar; 209(6):727-737. PubMed ID: 38117233
    [No Abstract]   [Full Text] [Related]  

  • 14. Donor-derived cell-free DNA predicts allograft failure and mortality after lung transplantation.
    Agbor-Enoh S; Wang Y; Tunc I; Jang MK; Davis A; De Vlaminck I; Luikart H; Shah PD; Timofte I; Brown AW; Marishta A; Bhatti K; Gorham S; Fideli U; Wylie J; Grimm D; Goodwin N; Yang Y; Patel K; Zhu J; Iacono A; Orens JB; Nathan SD; Marboe C; Berry GJ; Quake SR; Khush K; Valantine HA
    EBioMedicine; 2019 Feb; 40():541-553. PubMed ID: 30692045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusing capacity of the lung for carbon monoxide: association with long-term outcomes after lung transplantation in a 20-year longitudinal study.
    Darley DR; Ma J; Huszti E; Ghany R; Hutcheon M; Chow CW; Tikkanen J; Keshavjee S; Singer LG; Martinu T
    Eur Respir J; 2022 Jan; 59(1):. PubMed ID: 34172463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Organizing pneumonia is associated with molecular allograft injury and the development of antibody-mediated rejection.
    Keller MB; Tian X; Jang MK; Meda R; Charya A; Ozisik D; Berry GJ; Marboe CC; Kong H; Ponor IL; Aryal S; Orens JB; Shah PD; Nathan SD; Agbor-Enoh S
    J Heart Lung Transplant; 2024 Apr; 43(4):563-570. PubMed ID: 37972825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of donor smoking and substance use on post-lung transplant outcomes.
    Rappaport JM; Siddiqui HU; Thuita L; Budev M; McCurry KR; Blackstone EH; Ahmad U;
    J Thorac Cardiovasc Surg; 2023 Aug; 166(2):383-393.e13. PubMed ID: 36967372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Both Pre-Transplant and Early Post-Transplant Antireflux Surgery Prevent Development of Early Allograft Injury After Lung Transplantation.
    Lo WK; Goldberg HJ; Wee J; Fisichella PM; Chan WW
    J Gastrointest Surg; 2016 Jan; 20(1):111-8; discussion 118. PubMed ID: 26493975
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Risk Factors and Prognostic Model for Primary Graft Dysfunction after Lung Transplantation in Patients with Pulmonary Hypertension.
    Porteous MK; Lee JC; Lederer DJ; Palmer SM; Cantu E; Shah RJ; Bellamy SL; Lama VN; Bhorade SM; Crespo MM; McDyer JF; Wille KM; Localio AR; Orens JB; Shah PD; Weinacker AB; Arcasoy S; Wilkes DS; Ware LB; Christie JD; Kawut SM; Diamond JM;
    Ann Am Thorac Soc; 2017 Oct; 14(10):1514-1522. PubMed ID: 28719755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase-resolved Functional Lung (PREFUL) MRI-derived Ventilation and Perfusion Parameters Predict Future Lung Transplant Loss.
    Vogel-Claussen J; Kaireit TF; Voskrebenzev A; Klimeš F; Glandorf J; Behrendt L; Gutberlet M; Korz C; Speth M; Welte T; Wacker F; Gottlieb J
    Radiology; 2023 May; 307(4):e221958. PubMed ID: 37070996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.